Literature DB >> 3342156

Regression of coronary atherosclerosis: is it possible?

J Shepherd, C J Packard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3342156      PMCID： PMC1276976          DOI： 10.1136/hrt.59.2.149

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


× No keyword cloud information.
  11 in total

1.  Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men.

Authors:  M J Martin; S B Hulley; W S Browner; L H Kuller; D Wentworth
Journal:  Lancet       Date:  1986-10-25       Impact factor: 79.321

2.  The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery.

Authors:  L Campeau; M Enjalbert; J Lespérance; M G Bourassa; P Kwiterovich; S Wacholder; A Sniderman
Journal:  N Engl J Med       Date:  1984-11-22       Impact factor: 91.245

3.  The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study.

Authors:  R I Levy; J F Brensike; S E Epstein; S F Kelsey; E R Passamani; J M Richardson; I K Loh; N J Stone; R F Aldrich; J W Battaglini
Journal:  Circulation       Date:  1984-02       Impact factor: 29.690

4.  Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.

Authors:  M H Frick; O Elo; K Haapa; O P Heinonen; P Heinsalmi; P Helo; J K Huttunen; P Kaitaniemi; P Koskinen; V Manninen
Journal:  N Engl J Med       Date:  1987-11-12       Impact factor: 91.245

5.  Diet, lipoproteins, and the progression of coronary atherosclerosis. The Leiden Intervention Trial.

Authors:  A C Arntzenius; D Kromhout; J D Barth; J H Reiber; A V Bruschke; B Buis; C M van Gent; N Kempen-Voogd; S Strikwerda; E A van der Velde
Journal:  N Engl J Med       Date:  1985-03-28       Impact factor: 91.245

6.  Prevention of progression of coronary atherosclerosis by treatment of hyperlipidaemia: a seven year prospective angiographic study.

Authors:  E A Nikkilä; P Viikinkoski; M Valle; M H Frick
Journal:  Br Med J (Clin Res Ed)       Date:  1984-07-28

7.  Cholesterol turnover in lipid phases of human atherosclerotic plaque.

Authors:  S S Katz; D M Small; F R Smith; R B Dell; D S Goodman
Journal:  J Lipid Res       Date:  1982-07       Impact factor: 5.922

8.  Mevinolin plus colestipol in therapy for severe heterozygous familial hypercholesterolemia.

Authors:  D R Illingworth
Journal:  Ann Intern Med       Date:  1984-11       Impact factor: 25.391

9.  Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts.

Authors:  D H Blankenhorn; S A Nessim; R L Johnson; M E Sanmarco; S P Azen; L Cashin-Hemphill
Journal:  JAMA       Date:  1987-06-19       Impact factor: 56.272

10.  Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.

Authors:  A W Alberts; J Chen; G Kuron; V Hunt; J Huff; C Hoffman; J Rothrock; M Lopez; H Joshua; E Harris; A Patchett; R Monaghan; S Currie; E Stapley; G Albers-Schonberg; O Hensens; J Hirshfield; K Hoogsteen; J Liesch; J Springer
Journal:  Proc Natl Acad Sci U S A       Date:  1980-07       Impact factor: 11.205
View more
  2 in total

1.  Regression of atherosclerosis.

Authors:  S Moore
Journal:  CMAJ       Date:  1990-09-15       Impact factor: 8.262

2.  Chemical shift magnetic resonance imaging of human atheroma.

Authors:  R H Mohiaddin; D N Firmin; S R Underwood; A K Abdulla; R H Klipstein; R S Rees; D B Longmore
Journal:  Br Heart J       Date:  1989-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.